메뉴 건너뛰기




Volumn 34, Issue 5, 2008, Pages 581-586

The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study

Author keywords

111In pentetreotide scan; 18F FDG PET CT; Contrast enhanced CT; High resolution neck ultrasound; Metastatic medullary thyroid carcinoma (MTC); Serum calcitonin

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; TETRAAZACYCLODODECANE TETRAACETIC ACID DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLTHREONYLCYSTEINYLTHREONINOL YTTRIUM 90; UNCLASSIFIED DRUG; YTTRIUM 90; CALCITONIN; DIAGNOSTIC AGENT;

EID: 41949099184     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.08.005     Document Type: Article
Times cited : (57)

References (10)
  • 1
    • 33750509391 scopus 로고    scopus 로고
    • Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases
    • Roman S., Lin R., and Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107 9 (2006) 2134-2142
    • (2006) Cancer , vol.107 , Issue.9 , pp. 2134-2142
    • Roman, S.1    Lin, R.2    Sosa, JA.3
  • 3
    • 33748709257 scopus 로고    scopus 로고
    • Medullary thyroid carcinoma-update and present management controversies
    • Al-Rawi M., and Wheeler M.H. Medullary thyroid carcinoma-update and present management controversies. Ann R Coll Surg Engl 88 5 (2006) 433-438
    • (2006) Ann R Coll Surg Engl , vol.88 , Issue.5 , pp. 433-438
    • Al-Rawi, M.1    Wheeler, M.H.2
  • 4
    • 33645878621 scopus 로고    scopus 로고
    • Georgoulias, et al. Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    • Koukouraki S., and Strauss L.G. Georgoulias, et al. Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 33 4 (2006) 460-466
    • (2006) Eur J Nucl Med Mol Imaging , vol.33 , Issue.4 , pp. 460-466
    • Koukouraki, S.1    Strauss, L.G.2
  • 5
    • 34547737564 scopus 로고    scopus 로고
    • Recent advances in treatment of medullary thyroid carcinoma
    • Vezzosi D., Bennet A., and Caron P. Recent advances in treatment of medullary thyroid carcinoma. Ann Endocrinol (Paris) 68 2-3 (2007) e37-e43
    • (2007) Ann Endocrinol (Paris) , vol.68 , Issue.2-3
    • Vezzosi, D.1    Bennet, A.2    Caron, P.3
  • 6
    • 34248594179 scopus 로고    scopus 로고
    • Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
    • Ong S.C., Schoder H., Patel S.G., et al. Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 48 4 (2007) 501-507
    • (2007) J Nucl Med , vol.48 , Issue.4 , pp. 501-507
    • Ong, S.C.1    Schoder, H.2    Patel, S.G.3
  • 7
    • 6944231270 scopus 로고    scopus 로고
    • Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer
    • de Groot J.W., Links T.P., Jager P.L., Kahraman T., and Plukker J.T. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 11 8 (2004) 786-794
    • (2004) Ann Surg Oncol , vol.11 , Issue.8 , pp. 786-794
    • de Groot, J.W.1    Links, T.P.2    Jager, P.L.3    Kahraman, T.4    Plukker, J.T.5
  • 8
    • 27644511254 scopus 로고    scopus 로고
    • Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinoma
    • Khan N., Oriuchi N., Higuchi T., and Endo K. Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinoma. Cancer Control 12 4 (2005) 254-260
    • (2005) Cancer Control , vol.12 , Issue.4 , pp. 254-260
    • Khan, N.1    Oriuchi, N.2    Higuchi, T.3    Endo, K.4
  • 9
    • 33847411464 scopus 로고    scopus 로고
    • Detection of occult medullary thyroid cancer recurrence with 2-deeoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT
    • Iagaru A., Masamed R., Singer P.A., and Conti P.S. Detection of occult medullary thyroid cancer recurrence with 2-deeoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. Mol Imaging Biol 9 2 (2007) 72-77
    • (2007) Mol Imaging Biol , vol.9 , Issue.2 , pp. 72-77
    • Iagaru, A.1    Masamed, R.2    Singer, P.A.3    Conti, P.S.4
  • 10
    • 16544377183 scopus 로고    scopus 로고
    • 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature
    • Gotthardt M., Battmann A., Hoffken H., et al. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Commun 25 5 (2004) 439-443
    • (2004) Nucl Med Commun , vol.25 , Issue.5 , pp. 439-443
    • Gotthardt, M.1    Battmann, A.2    Hoffken, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.